You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Polychondritis, Relapsing

Showing 1 - 25 of 985
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pediatric Relapsing Polychondritis : Diagnosis and Management

Recruiting
  • Relapsing Polychondritis
    • Strasbourg, France
      Service de Pédiatrie 1 - CHU de Strasbourg - France
    Aug 24, 2023

    Longitudinal Study for Relapsing Polychondritis

    Recruiting
    • Relapsing Polychondritis
    • Vasculitis
      • Philadelphia, Pennsylvania
        University of Pennsylvania
      Jul 11, 2022

      Pathogenesis, and Outcome of Idiopathic Systemic Vasculitis

      Recruiting
      • Takayasu's Arteritis
      • +4 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Jan 25, 2023

        Physical Activity Trial in Sao Paulo (Physical training)

        Completed
        • Physical Activity
        • Physical training
        • Sao Paulo, Brazil
          Samuel Katsuyuki Shinjo
        Apr 29, 2021

        Relapsing Polychondritis Trial in Ottawa (Tocilizumab)

        Completed
        Has Results
        • Relapsing Polychondritis
        • Ottawa, Ontario, Canada
          Children's Hospital of Eastern Ontario
        Feb 11, 2021

        Giant Cell Arteritis, Takayasu Arteritis, Cogan Syndrome Trial in Cambridge, Glasgow, London (Rituximab, Infliximab,

        Recruiting
        • Giant Cell Arteritis
        • +8 more
        • Rituximab
        • +2 more
        • Cambridge, United Kingdom
        • +2 more
        Dec 9, 2021

        Relapsing Polychondritis Trial (Interleukin-2)

        Unknown status
        • Relapsing Polychondritis
        • (no location specified)
        Sep 1, 2019

        Adverse Drug Events Associated With Initiation of Drugs

        Completed
        • COVID
        • +3 more
        • Simulation of Repurposed Drugs for COVID-19
        • Orlando, Florida
          Tabula Rasa HealthCare Precision Pharmacotherapy Research and De
        Jan 30, 2023

        Pulmonary Disease Trial in Nashville (Spray cryotherapy, Ballon Dilation, Radial Incision)

        Recruiting
        • Pulmonary Disease
        • Spray cryotherapy
        • +2 more
        • Nashville, Tennessee
          Vanderbilt University Medical Center
        Mar 18, 2022

        Immunodeficiency, Hematopoietic Stem Cell Transplantation Trial run by the National Cancer Institute (NCI) (drug, radiation,

        Recruiting
        • Immunodeficiency
        • Hematopoietic Stem Cell Transplantation
        • Post-Transplant Cyclophosphamide (PTCY)
        • +8 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Aug 17, 2022

        Relapsing Multiple Sclerosis, Multiple Sclerosis Trial (Placebo, Pirtobrutinib)

        Not yet recruiting
        • Relapsing Multiple Sclerosis
        • Multiple Sclerosis
        • (no location specified)
        Oct 24, 2023

        Multiple Sclerosis, Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Secondary Progressive Trial in Palo Alto

        Not yet recruiting
        • Multiple Sclerosis
        • +2 more
        • KYV-101 anti-CD19 CAR-T cell therapy
        • Standard lymphodepletion regimen
        • Palo Alto, California
          Stanford Multiple Sclerosis Center
        Nov 13, 2023

        Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting Trial in Saint Louis (Cladribine)

        Recruiting
        • Multiple Sclerosis
        • Multiple Sclerosis, Relapsing-Remitting
        • Saint Louis, Missouri
        • +4 more
        Jan 4, 2023

        Multiple Sclerosis Trial in Elazig (Yoga)

        Not yet recruiting
        • Multiple Sclerosis
        • Yoga
        • Elazığ, Turkey
          Gülcan Bahçecioğlu TURAN
        Nov 7, 2023

        Nephrotic Syndrome in Children, Telitacicept Trial in Hangzhou (Telitacicept)

        Recruiting
        • Nephrotic Syndrome in Children
        • Telitacicept
        • Hangzhou, Zhejiang, China
          Children's Hospital, Zhejiang University School of Medicine
        Nov 8, 2023

        Multiple Sclerosis Trial in Worldwide (SAR443820, Placebo)

        Recruiting
        • Multiple Sclerosis
        • Bruxelles, Belgium
        • +16 more
        Jan 31, 2023

        Bafiertam Treatment In Routine Clinical Practice

        Enrolling by invitation
        • Relapsing Remitting Multiple Sclerosis
        • Monomethyl Fumarate
        • West Hollywood, California
        • +1 more
        Aug 3, 2023

        Inflammatory Disease in Multiple Sclerosis

        Active, not recruiting
        • Relapsing Multiple Sclerosis
        • Multiple Sclerosis
        • Cerebrospinal and Blood Serum Semaphorin 4A Levels
        • Portland, Oregon
          Providence St. Vincent Medical Center
        May 19, 2022

        Nephrotic Syndrome Trial in United States (ADX-629)

        Not yet recruiting
        • Nephrotic Syndrome
        • Northridge, California
        • +10 more
        Jan 24, 2023

        Concentration of BRIUMVI™ (Ublituximab) in Breast Milk

        Not yet recruiting
        • Relapsing Multiple Sclerosis
        • No intervention
        • (no location specified)
        Nov 16, 2023

        Relapsing-remitting Multiple Sclerosis Trial (CT-P53, US-Ocrevus, EU-Ocrevus)

        Not yet recruiting
        • Relapsing-remitting Multiple Sclerosis
        • CT-P53
        • +2 more
        • (no location specified)
        Jun 7, 2023

        Multiple Sclerosis Trial in Worldwide (IMU-838 tablets, Placebo matching IMU-838 tablets)

        Recruiting
        • Multiple Sclerosis
        • IMU-838 tablets
        • Placebo matching IMU-838 tablets
        • Phoenix, Arizona
        • +58 more
        Jan 31, 2023

        Idiopathic Membranous Nephropathy Trial in Beijing

        Recruiting
        • Idiopathic Membranous Nephropathy
          • Beijing, Beijing, China
          • +2 more
          Jan 18, 2023

          Steroid-Dependent Nephrotic Syndrome, Steroid-Sensitive Nephrotic Syndrome Trial in Paris (single infusion of Rituximab, single

          Not yet recruiting
          • Steroid-Dependent Nephrotic Syndrome
          • Steroid-Sensitive Nephrotic Syndrome
          • single infusion of Rituximab
          • single infusion of Obinutuzumab
          • Paris, France
            Robert Debre Hospital
          Mar 14, 2023

          COVID-19 Vaccination in Rare and Complex Connective Tissue

          Not yet recruiting
          • Connective Tissue Diseases
          • +2 more
            • (no location specified)
            Jan 7, 2021